Neuroprotective and Anti-Inflammatory Effects of Evernic Acid in an MPTP-Induced Parkinson’s Disease Model

Oxidative stress, mitochondrial dysfunction, and neuroinflammation are strongly associated with the pathogenesis of Parkinson’s disease (PD), which suggests that anti-oxidative and anti-inflammatory compounds might provide an alternative treatment for PD. Here, we evaluated the neuroprotective effects of evernic aid (EA), which was screened from a lichen library provided by the Korean Lichen Research Institute at Sunchon National University. EA is a secondary metabolite generated by lichens, including Ramalina, Evernia, and Hypogymnia, and several studies have described its anticancer, antifungal, and antimicrobial effects. However, the neuroprotective effects of EA have not been studied. We found that EA protected primary cultured neurons against 1-methyl-4-phenylpyridium (MPP⁺)-induced cell death, mitochondrial dysfunction, and oxidative stress, and effectively reduced MPP⁺-induced astroglial activation by inhibiting the NF-κB pathway. In vivo, EA ameliorated MPTP-induced motor dysfunction, dopaminergic neuronal loss, and neuroinflammation in the nigrostriatal pathway in C57BL/6 mice. Taken together, our findings demonstrate that EA has neuroprotective and anti-inflammatory effects in PD models and suggest that EA is a potential therapeutic candidate for PD.     

纳米药物非临床药代动力学的研究策略及关注要点

随着纳米技术的迅速发展，纳米药物的研发已成为目前药物创新的发展方向之一。纳米药物具有基于纳米结构的尺度效应，其药代动力学特征与普通药物相比存在明显差异，其药代动力学研究与普通药物相比也有其特殊性。本文着重探讨纳米药物的非临床药代动力学的研究策略及关注要点，包括受试物、体内/外试验、生物样本分析、数据评价分析等，期望为研发者提供参考。     

Chemical Bonding by the Chemical Orthogonal Space of Reactivity

The fashionable Parr–Pearson (PP) atoms-in-molecule/bonding (AIM/AIB) approach for determining the exchanged charge necessary for acquiring an equalized electronegativity within a chemical bond is refined and generalized here by introducing the concepts of chemical power within the chemical orthogonal space (COS) in terms of electronegativity and chemical hardness. Electronegativity and chemical hardness are conceptually orthogonal, since there are opposite tendencies in bonding, i.e., reactivity vs. stability or the HOMO-LUMO middy level vs. the HOMO-LUMO interval (gap). Thus, atoms-in-molecule/bond electronegativity and chemical hardness are provided for in orthogonal space (COS), along with a generalized analytical expression of the exchanged electrons in bonding. Moreover, the present formalism surpasses the earlier Parr–Pearson limitation to the context of hetero-bonding molecules so as to also include the important case of covalent homo-bonding. The connections of the present COS analysis with PP formalism is analytically revealed, while a numerical illustration regarding the patterning and fragmentation of chemical benchmarking bondings is also presented and fundamental open questions are critically discussed.     

Preparation and Evaluation of a Self-Nanoemulsifying Drug Delivery System Loaded with Heparin Phospholipid Complex

A self-nanoemulsifying drug delivery system (SNEDDS) was developed to enhance the absorption of heparin after oral administration, in which heparin was compounded with phospholipids to achieve better fat solubility in the form of heparin-phospholipid (HEP-Pc) complex. HEP-Pc complex was prepared using the solvent evaporation method, which increased the solubility of heparin in n-octanol. The successful preparation of HEP-Pc complex was confirmed by differential scanning calorimetry (DSC), Fourier-transform infrared (FT-IR) spectroscopy, NMR, and SEM. A heparin lipid microemulsion (HEP-LM) was prepared by high-pressure homogenization and characterized. HEP-LM can enhance the absorption of heparin after oral administration, significantly prolong activated partial thromboplastin time (APTT) and thrombin time (TT) in mice, and reduce fibrinogen (FIB) content. All these outcomes indicate that HEP-LM has great potential as an oral heparin formulation.     

Constitutive model and failure criterion for orthotropic ceramic matrix composites under macroscopic plane stress

To predict the nonlinear stress-strain behavior and the rupture strength of orthotropic ceramic matrix composites (CMCs) under macroscopic plane stress, a concise damage-based mechanical theory including a new constitutive model and two kinds of failure criteria was developed in the framework of continuum damage mechanics (CDM). The damage constitutive model was established using strain partitioning and damage decoupling methods. Meanwhile, the failure criteria were formulated in terms of damage energy release rate (DERR) in order to correlate the failure property of CMCs with damage driving forces, and the maximum DERR criterion and the interactive DERR criterion were suggested simultaneously. For the sake of model evaluation, the theory was applied to a typical CMC with damageable and nonlinear behavior, that is, 2D-C/SiC. The damage evolution law, strain response and rupture strength under incremental cyclic tension along both on-axis and off-axis directions were completely investigated. Comparison between theoretical predictions and experimental data illustrates that the newly developed mechanical theory is potential to give reasonable and accurate results of both stress-strain response and failure property for orthotropic CMCs.     

Structural,ferroelectric, magnetic and magnetoelectric properties of (1-x) Ba0.85Ca0.15Zr0.1Ti0.9O3 -x La0.67Sr0.33MnO3 lead-free magnetoelectric composites

The influence of an additional La_0.67Sr_0.33MnO₃ (LSMO) magnetic phase on the structural, ferromagnetic, ferroelectric, and magnetoelectric properties of Ba_0.85Ca_0.15Zr_0.1Ti_0.9O₃ (BCZT) ferroelectric phase was studied for composites of (1-x)BCZT -xLSMO (x = 0, 25, 50, 75 and 100%). The ferroelectric BCZT sample showed a perovskite single phase formation with a tetragonal crystal structure of the P4mm space group, and the magnetic phase of LSMO presented a rhombohedral crystal structure of R3c space group as shown by XRD. The composite sample with 25% LSMO exhibited large ferroelectric and piezoelectric properties with remnant, saturation polarization, and coercive electric field P_r ~7.74 μC/cm², P_s ~11.69 μC/cm² and E_C ~12.22 kV/cm with a piezoelectric coefficient d₃₃ ~ 231 pC/N. The magnetic characterization for the composites showed that the sample containing 75% of LSMO revealed the highest remnant, saturation magnetization, and coercive field of M_r ~1.358 emu/g, M_s ~19.17 emu/g, and H_C ~33.19 Oe, respectively. Moreover, it revealed the largest magnetoelectric coupling coefficient α_ME ~2.51 mV/cm.Oe with high coupling quality at a lower applied magnetic field. The results highlight the value of these composites as lead-free room temperature magnetoelectric sensors and actuators.     

Hereditary Prostate Cancer: Genes Related,Target Therapy and Prevention

Prostate cancer (PCa) is globally the second most diagnosed cancer type and the most common cause of cancer-related deaths in men. Family history of PCa, hereditary breast and ovarian cancer (HBOC) and Lynch syndromes (LS), are among the most important risk factors compared to age, race, ethnicity and environmental factors for PCa development. Hereditary prostate cancer (HPCa) has the highest heritability of any major cancer in men. The proportion of PCa attributable to hereditary factors has been estimated in the range of 5–15%. To date, the genes more consistently associated to HPCa susceptibility include mismatch repair (MMR) genes (MLH1, MSH2, MSH6, and PMS2) and homologous recombination genes (BRCA1/2, ATM, PALB2, CHEK2). Additional genes are also recommended to be integrated into specific research, including HOXB13, BRP1 and NSB1. Importantly, BRCA1/BRCA2 and ATM mutated patients potentially benefit from Poly (ADP-ribose) polymerase PARP inhibitors, through a mechanism of synthetic lethality, causing selective tumor cell cytotoxicity in cell lines. Moreover, the detection of germline alterations in MMR genes has therapeutic implications, as it may help to predict immunotherapy benefits. Here, we discuss the current knowledge of the genetic basis for inherited predisposition to PCa, the potential target therapy, and the role of active surveillance as a management strategy for patients with low-risk PCa. Finally, the current PCa guideline recommendations are reviewed.